Smoking
Conditions
Keywords
smoking, smoke cessation, stop smoking, quit smoking, nicotine replacement therapy, Smoke Break, liquid cigarette, liquid nicotine cigarette
Brief summary
The purpose of this study is to determine whether the Smoke-Break nicotine delivery device can help smokers quit smoking, while avoiding many of the side effects associated with other smoking cessation products.
Detailed description
The study has been completed and published. The published study manuscript can be found here: http://www.biomedcentral.com/1471-2458/10/155
Interventions
DRUGNicotine
Subjects received an amount of liquid nicotine cigarettes (containing 1.5mg of nicotine each) based on the amount of nicotine the subjects had been receiving from cigarettes. The number of liquid nicotine cigarettes received by each subject was reviewed, and adjusted (if necessary), every two weeks for the duration of the 12-week study.
DEVICESmoke-Break nicotine delivery device
The Smoke-Break nicotine delivery device is a liquid nicotine cigarette designed to mimic the act of smoking. It is an NRT (nicotine replacement therapy) similar in concept to the nicotine patch, gum, and lozenge, except the nicotine is delivered in a way designed to duplicate the cigarette smoking experience. The Smoke-Break nicotine delivery device is non-invasive.
Sponsors
Smoke-Break, Inc.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Volunteer is at least 18 years of age. * Volunteer currently smokes cigarettes, cigars or other forms of tobacco products for at least one year. * Volunteer wants to quit smoking. * Volunteer will be fully informed as to the nature of the study. * Volunteer will have no known allergy to any product ingredients as listed in the informed consent. * Volunteer agrees to a confidential pretest questionnaire and periodic monitoring as to the effectiveness of the smoking cessation regimen. * Volunteers are not currently using another nicotine replacement therapy. * Volunteer will agree to use birth control measures while on the study.
Exclusion criteria
* Volunteer has a known allergy or hypersensitivity to nicotine or other related ingredients as outlined in the informed consent. * Volunteer does not desire to quit smoking. * Volunteer is using another nicotine replacement therapy. * Volunteer is pregnant or breast-feeding. * Volunteer has a history of heart disease or advanced diabetes. * Volunteer indicates on the application that they smoke ten (10) or fewer cigarettes per day. * Volunteer is using a daily prescription medicine for depression or asthma. * Volunteer is using a non-nicotine smoke cessation drug, such as Zyban or Chantix. * Volunteer is an employee of Smoke-Break Inc., or is personally known to an employee of Smoke-Break Inc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Smoke cessation | 12 weeks |
Secondary
| Measure | Time frame |
|---|---|
| Side effects | 0-12 weeks |
Countries
United States
Outcome results
None listed